( 0 1 0 1 O
> 1 2 1 2 O
85th 2 6 2 6 B-lower_bound
BMI% 7 11 7 11 B-bmi
) 11 12 11 12 O

( 0 1 13 14 O
e.g. 1 5 14 18 O
, 5 6 18 19 O
known 7 12 20 25 O
or 13 15 26 28 O
suspected 16 25 29 38 O
congestive 26 36 39 49 B-chronic_disease
heart 37 42 50 55 I-chronic_disease
failure 43 50 56 63 I-chronic_disease
; 50 51 63 64 O
asthma 52 58 65 71 B-chronic_disease
requiring 59 68 72 81 O
intermittent 69 81 82 94 O
systemic 82 90 95 103 B-treatment
corticosteroids 91 106 104 119 I-treatment
; 106 107 119 120 O
etc 108 111 121 124 O
. 111 112 124 125 O
) 112 113 125 126 O

( 0 1 127 128 O
expected 1 9 128 136 O
age 10 13 137 140 B-age
range 14 19 141 146 O
7 20 21 147 148 B-lower_bound
- 21 22 148 149 O
18 22 24 149 151 B-upper_bound
) 24 25 151 152 O

( 0 1 153 154 O
free 1 5 154 158 B-clinical_variable
testosterone 6 18 159 171 I-clinical_variable
greater 19 26 172 179 O
than 27 31 180 184 O
2.5 32 35 185 188 B-lower_bound
standard 36 44 189 197 I-lower_bound
deviations 45 55 198 208 I-lower_bound
above 56 61 209 214 I-lower_bound
the 62 65 215 218 I-lower_bound
mean 66 70 219 223 I-lower_bound
for 71 74 224 227 O
normal 75 81 228 234 O
control 82 89 235 242 O
subjects 90 98 243 251 O
of 99 101 252 254 O
the 102 105 255 258 O
same 106 110 259 263 O
Tanner 111 117 264 270 O
Stage 118 123 271 276 O
) 123 124 276 277 O

( 0 1 278 279 O
mild 1 5 279 283 O
elevations 6 16 284 294 B-clinical_variable
may 17 20 295 298 O
be 21 23 299 301 O
seen 24 28 302 306 O
in 29 31 307 309 O
polycystic 32 42 310 320 B-chronic_disease
ovary 43 48 321 326 I-chronic_disease
syndrome 49 57 327 335 I-chronic_disease
( 58 59 336 337 I-chronic_disease
PCOS 59 63 337 341 I-chronic_disease
) 63 64 341 342 I-chronic_disease
and 65 68 343 346 O
adolescent 69 79 347 357 O
hyperandrogenemia 80 97 358 375 B-chronic_disease
( 98 99 376 377 I-chronic_disease
HA 99 101 377 379 I-chronic_disease
) 101 102 379 380 I-chronic_disease
, 102 103 380 381 O
and 104 107 382 385 O
elevations 108 118 386 396 O
< 119 120 397 398 O
1.5 121 124 399 402 B-upper_bound
times 125 130 403 408 I-upper_bound
the 131 134 409 412 I-upper_bound
age 135 138 413 416 I-upper_bound
- 138 139 416 417 I-upper_bound
appropriate 139 150 417 428 I-upper_bound
upper 151 156 429 434 I-upper_bound
limit 157 162 435 440 I-upper_bound
of 163 165 441 443 I-upper_bound
normal 166 172 444 450 I-upper_bound
will 173 177 451 455 O
be 178 180 456 458 O
accepted 181 189 459 467 O
in 190 192 468 470 O
these 193 198 471 476 O
groups 199 205 477 483 O
) 205 206 483 484 O

Abnormal 0 8 485 493 B-chronic_disease
prolactin 9 18 494 503 I-chronic_disease
. 18 19 503 504 O
Mild 20 24 505 509 O
elevations 25 35 510 520 B-ethnicity
may 36 39 521 524 O
be 40 42 525 527 O
seen 43 47 528 532 O
in 48 50 533 535 O
overweight 51 61 536 546 O
girls 62 67 547 552 O
, 67 68 552 553 O
and 69 72 554 557 O
elevations 73 83 558 568 O
< 84 85 569 570 O
1.5 85 88 570 573 B-upper_bound
times 89 94 574 579 I-upper_bound
the 95 98 580 583 I-upper_bound
upper 99 104 584 589 I-upper_bound
limit 105 110 590 595 I-upper_bound
of 111 113 596 598 I-upper_bound
normal 114 120 599 605 I-upper_bound
will 121 125 606 610 O
be 126 128 611 613 O
accepted 129 137 614 622 O
in 138 140 623 625 O
this 141 145 626 630 O
group 146 151 631 636 O

Abnormal 0 8 637 645 B-chronic_disease
thyroid 9 16 646 653 I-chronic_disease
stimulating 17 28 654 665 I-chronic_disease
hormone 29 36 666 673 I-chronic_disease
( 37 38 674 675 I-chronic_disease
TSH 38 41 675 678 I-chronic_disease
) 41 42 678 679 I-chronic_disease
for 43 46 680 683 O
age 47 50 684 687 B-age

Age 0 3 688 691 B-age
< 4 5 692 693 O
7 6 7 694 695 B-upper_bound
or 8 10 696 698 O
> 11 12 699 700 O
18 13 15 701 703 B-lower_bound
y 16 17 704 705 I-lower_bound

BMI 0 3 706 709 B-bmi
- 3 4 709 710 O
for 4 7 710 713 O
- 7 8 713 714 O
age 8 11 714 717 B-age
< 12 13 718 719 O
5th 14 17 720 723 B-upper_bound
percentile 18 28 724 734 I-upper_bound

History 0 7 735 742 O
of 8 10 743 745 O
congenital 11 21 746 756 B-chronic_disease
adrenal 22 29 757 764 I-chronic_disease
hyperplasia 30 41 765 776 I-chronic_disease
or 42 44 777 779 O
17 45 47 780 782 B-clinical_variable
- 47 48 782 783 I-clinical_variable
hydroxyprogesterone 48 67 783 802 I-clinical_variable
> 68 69 803 804 O
300 70 73 805 808 B-lower_bound
ng 74 76 809 811 I-lower_bound
/ 76 77 811 812 I-lower_bound
dL 77 79 812 814 I-lower_bound
, 79 80 814 815 O
which 81 86 816 821 O
suggests 87 95 822 830 O
the 96 99 831 834 O
possibility 100 111 835 846 O
of 112 114 847 849 O
congenital 115 125 850 860 O
adrenal 126 133 861 868 O
hyperplasia 134 145 869 880 O

Hyperandrogenemic 0 17 881 898 B-chronic_disease

Mild 0 4 899 903 O
elevations 5 15 904 914 B-clinical_variable
may 16 19 915 918 O
be 20 22 919 921 O
seen 23 27 922 926 O
in 28 30 927 929 O
overweight 31 41 930 940 O
girls 42 47 941 946 O
, 47 48 946 947 O
so 49 51 948 950 O
elevations 52 62 951 961 O
< 63 64 962 963 O
1.5 64 67 963 966 B-upper_bound
times 68 73 967 972 I-upper_bound
the 74 77 973 976 I-upper_bound
upper 78 83 977 982 I-upper_bound
limit 84 89 983 988 I-upper_bound
of 90 92 989 991 I-upper_bound
normal 93 99 992 998 I-upper_bound
will 100 104 999 1003 O
be 105 107 1004 1006 O
accepted 108 116 1007 1015 O
in 117 119 1016 1018 O
this 120 124 1019 1023 O
group 125 130 1024 1029 O

Morning 0 7 1030 1037 O
cortisol 8 16 1038 1046 B-treatment
< 17 18 1047 1048 O
3 19 20 1049 1050 B-upper_bound
µg 21 23 1051 1053 I-upper_bound
/ 23 24 1053 1054 I-upper_bound
dL 24 26 1054 1056 I-upper_bound
or 27 29 1057 1059 O
history 30 37 1060 1067 O
of 38 40 1068 1070 O
Cushing 41 48 1071 1078 B-chronic_disease
syndrome 49 57 1079 1087 I-chronic_disease
or 58 60 1088 1090 O
adrenal 61 68 1091 1098 B-chronic_disease
insufficiency 69 82 1099 1112 I-chronic_disease

No 0 2 1113 1115 O
medications 3 14 1116 1127 B-treatment
known 15 20 1128 1133 O
to 21 23 1134 1136 O
affect 24 30 1137 1143 O
the 31 34 1144 1147 O
reproductive 35 47 1148 1160 O
system 48 54 1161 1167 O
or 55 57 1168 1170 O
glucose 58 65 1171 1178 O
metabolism 66 76 1179 1189 O
can 77 80 1190 1193 O
be 81 83 1194 1196 O
taken 84 89 1197 1202 O
in 90 92 1203 1205 O
the 93 96 1206 1209 O
3 97 98 1210 1211 O
months 99 105 1212 1218 O
prior 106 111 1219 1224 O
to 112 114 1225 1227 O
the 115 118 1228 1231 O
study 119 124 1232 1237 O
. 124 125 1237 1238 O
Such 126 130 1239 1243 O
medications 131 142 1244 1255 O
include 143 150 1256 1263 O
oral 151 155 1264 1268 B-treatment
contraceptive 156 169 1269 1282 I-treatment
pills 170 175 1283 1288 I-treatment
, 175 176 1288 1289 O
progestins 177 187 1290 1300 B-treatment
, 187 188 1300 1301 O
metformin 189 198 1302 1311 B-treatment
, 198 199 1311 1312 O
glucocorticoids 200 215 1313 1328 B-treatment
, 215 216 1328 1329 O
and 217 220 1330 1333 O
psychotropics 221 234 1334 1347 B-treatment

Persistent 0 10 1348 1358 B-clinical_variable
hematocrit 11 21 1359 1369 I-clinical_variable
< 22 23 1370 1371 O
36 23 25 1371 1373 O
% 25 26 1373 1374 O
and 27 30 1375 1378 O
hemoglobin 31 41 1379 1389 B-clinical_variable
< 42 43 1390 1391 O
12 43 45 1391 1393 O
g 46 47 1394 1395 O
/ 47 48 1395 1396 O
dL. 48 51 1396 1399 O
Subjects 52 60 1400 1408 O
with 61 65 1409 1413 O
a 66 67 1414 1415 O
mildly 68 74 1416 1422 O
low 75 78 1423 1426 O
hematocrit 79 89 1427 1437 O
( 90 91 1438 1439 O
33 91 93 1439 1441 B-lower_bound
- 93 94 1441 1442 O
36 94 96 1442 1444 O
% 96 97 1444 1445 O
) 97 98 1445 1446 O
will 99 103 1447 1451 O
be 104 106 1452 1454 O
asked 107 112 1455 1460 O
to 113 115 1461 1463 O
take 116 120 1464 1468 O
iron 121 125 1469 1473 O
in 126 128 1474 1476 O
the 129 132 1477 1480 O
form 133 137 1481 1485 O
of 138 140 1486 1488 O
ferrous 141 148 1489 1496 B-treatment
gluconate 149 158 1497 1506 I-treatment
for 159 162 1507 1510 O
up 163 165 1511 1513 O
to 166 168 1514 1516 O
60 169 171 1517 1519 B-upper_bound
days 172 176 1520 1524 I-upper_bound
. 176 177 1524 1525 O
Subjects 178 186 1526 1534 O
weighing 187 195 1535 1543 O
≤ 196 197 1544 1545 O
36 198 200 1546 1548 O
kg 201 203 1549 1551 O
will 204 208 1552 1556 O
take 209 213 1557 1561 O
one 214 217 1562 1565 O
300 218 221 1566 1569 B-lower_bound
- 221 222 1569 1570 O
325 222 225 1570 1573 B-upper_bound
mg 226 228 1574 1576 I-upper_bound
tablet 229 235 1577 1583 O
oral 236 240 1584 1588 B-clinical_variable
ferrous 241 248 1589 1596 I-clinical_variable
gluconate 249 258 1597 1606 I-clinical_variable
daily 259 264 1607 1612 O
( 265 266 1613 1614 O
containing 266 276 1614 1624 O
36 277 279 1625 1627 O
mg 280 282 1628 1630 O
elemental 283 292 1631 1640 O
iron);subjects 293 307 1641 1655 O
weighing 308 316 1656 1664 O
> 317 318 1665 1666 O
36 318 320 1666 1668 O
kg 321 323 1669 1671 O
will 324 328 1672 1676 O
take 329 333 1677 1681 O
two 334 337 1682 1685 O
300 338 341 1686 1689 O
- 341 342 1689 1690 O
325 342 345 1690 1693 O
mg 346 348 1694 1696 O
tablets 349 356 1697 1704 O
oral 357 361 1705 1709 O
ferrous 362 369 1710 1717 O
gluconate 370 379 1718 1727 O
daily 380 385 1728 1733 O
( 386 387 1734 1735 O
containing 387 397 1735 1745 O
36 398 400 1746 1748 O
mg 401 403 1749 1751 O
elemental 404 413 1752 1761 O
iron 414 418 1762 1766 O
each 419 423 1767 1771 O
) 423 424 1771 1772 O
. 424 425 1772 1773 O
They 426 430 1774 1778 O
will 431 435 1779 1783 O
return 436 442 1784 1790 O
to 443 445 1791 1793 O
the 446 449 1794 1797 O
Clinical 450 458 1798 1806 O
Research 459 467 1807 1815 O
Unit 468 472 1816 1820 O
( 473 474 1821 1822 O
CRU 474 477 1822 1825 O
) 477 478 1825 1826 O
after 479 484 1827 1832 O
30 485 487 1833 1835 O
- 487 488 1835 1836 O
60 488 490 1836 1838 O
days 491 495 1839 1843 O
of 496 498 1844 1846 O
iron 499 503 1847 1851 B-treatment
therapy 504 511 1852 1859 I-treatment
to 512 514 1860 1862 O
have 515 519 1863 1867 O
their 520 525 1868 1873 O
hemoglobin 526 536 1874 1884 O
or 537 539 1885 1887 O
hematocrit 540 550 1888 1898 O
rechecked 551 560 1899 1908 O
and 561 564 1909 1912 O
will 565 569 1913 1917 O
proceed 570 577 1918 1925 O
with 578 582 1926 1930 O
the 583 586 1931 1934 O
remainder 587 596 1935 1944 O
of 597 599 1945 1947 O
the 600 603 1948 1951 O
study 604 609 1952 1957 O
if 610 612 1958 1960 O
it 613 615 1961 1963 O
is 616 618 1964 1966 O
≥12 619 622 1967 1970 O
g 623 624 1971 1972 O
/ 624 625 1972 1973 O
dL 625 627 1973 1975 O
or 628 630 1976 1978 O
≥36 631 634 1979 1982 O
% 634 635 1982 1983 O
, 635 636 1983 1984 O
respectively 637 649 1985 1997 O

Persistent 0 10 1998 2008 O
liver 11 16 2009 2014 B-chronic_disease
test 17 21 2015 2019 I-chronic_disease
abnormalities 22 35 2020 2033 I-chronic_disease
, 35 36 2033 2034 O
with 37 41 2035 2039 O
the 42 45 2040 2043 O
exception 46 55 2044 2053 O
that 56 60 2054 2058 O
mild 61 65 2059 2063 B-clinical_variable
bilirubin 66 75 2064 2073 I-clinical_variable
elevations 76 86 2074 2084 I-clinical_variable
will 87 91 2085 2089 O
be 92 94 2090 2092 O
accepted 95 103 2093 2101 O
in 104 106 2102 2104 O
the 107 110 2105 2108 O
setting 111 118 2109 2116 O
of 119 121 2117 2119 O
known 122 127 2120 2125 O
Gilbert 128 135 2126 2133 B-chronic_disease
's 135 137 2133 2135 I-chronic_disease
syndrome 138 146 2136 2144 I-chronic_disease

Positive 0 8 2145 2153 B-pregnancy
pregnancy 9 18 2154 2163 I-pregnancy
test 19 23 2164 2168 I-pregnancy

Previous 0 8 2169 2177 O
diagnosis 9 18 2178 2187 O
of 19 21 2188 2190 O
diabetes 22 30 2191 2199 B-chronic_disease
, 30 31 2199 2200 O
fasting 32 39 2201 2208 B-clinical_variable
glucose 40 47 2209 2216 I-clinical_variable
≥126 48 52 2217 2221 O
mg 53 55 2222 2224 I-lower_bound
/ 55 56 2224 2225 I-lower_bound
dL 56 58 2225 2227 I-lower_bound
, 58 59 2227 2228 O
or 60 62 2229 2231 O
a 63 64 2232 2233 O
hemoglobin 65 75 2234 2244 B-clinical_variable
A1c 76 79 2245 2248 I-clinical_variable
≥6.5 80 84 2249 2253 O
% 84 85 2253 2254 I-lower_bound

Screening 0 9 2255 2264 O
labs 10 14 2265 2269 O
within 15 21 2270 2276 O
age 22 25 2277 2280 B-age
- 25 26 2280 2281 O
appropriate 26 37 2281 2292 O
normal 38 44 2293 2299 O
range 45 50 2300 2305 O
, 50 51 2305 2306 O
with 52 56 2307 2311 O
the 57 60 2312 2315 O
exception 61 70 2316 2325 O
of 71 73 2326 2328 O
a 74 75 2329 2330 O
mildly 76 82 2331 2337 O
low 83 86 2338 2341 O
hematocrit 87 97 2342 2352 O
( 98 99 2353 2354 O
see 99 102 2354 2357 O
below 103 108 2358 2363 O
) 108 109 2363 2364 O
and 110 113 2365 2368 O
the 114 117 2369 2372 O
hormonal 118 126 2373 2381 O
abnormalities 127 140 2382 2395 O
inherent 141 149 2396 2404 O
in 150 152 2405 2407 O
obesity 153 160 2408 2415 O
which 161 166 2416 2421 O
could 167 172 2422 2427 O
include 173 180 2428 2435 O
mildly 181 187 2436 2442 O
elevated 188 196 2443 2451 O
luteinizing 197 208 2452 2463 B-clinical_variable
hormone 209 216 2464 2471 I-clinical_variable
( 217 218 2472 2473 I-clinical_variable
LH 218 220 2473 2475 I-clinical_variable
) 220 221 2475 2476 I-clinical_variable
, 221 222 2476 2477 O
lipids 223 229 2478 2484 O
, 229 230 2484 2485 O
testosterone 231 243 2486 2498 O
, 243 244 2498 2499 O
prolactin 245 254 2500 2509 O
, 254 255 2509 2510 O
DHEAS 256 261 2511 2516 B-clinical_variable
, 261 262 2516 2517 O
E2 263 265 2518 2520 B-clinical_variable
, 265 266 2520 2521 O
glucose 267 274 2522 2529 O
, 274 275 2529 2530 O
and 276 279 2531 2534 O
insulin 280 287 2535 2542 O
; 287 288 2542 2543 O
and 289 292 2544 2547 O
decreased 293 302 2548 2557 O
follicle 303 311 2558 2566 B-clinical_variable
- 311 312 2566 2567 I-clinical_variable
stimulating 312 323 2567 2578 I-clinical_variable
hormone 324 331 2579 2586 I-clinical_variable
( 332 333 2587 2588 I-clinical_variable
FSH 333 336 2588 2591 I-clinical_variable
) 336 337 2591 2592 I-clinical_variable
and/or 338 344 2593 2599 O
sex 345 348 2600 2603 B-clinical_variable
hormone 349 356 2604 2611 I-clinical_variable
- 356 357 2611 2612 I-clinical_variable
binding 357 364 2612 2619 I-clinical_variable
globulin 365 373 2620 2628 I-clinical_variable
( 374 375 2629 2630 I-clinical_variable
SHBG 375 379 2630 2634 I-clinical_variable
) 379 380 2634 2635 O

Significant 0 11 2636 2647 O
history 12 19 2648 2655 O
of 20 22 2656 2658 O
cardiac 23 30 2659 2666 B-chronic_disease
or 31 33 2667 2669 I-chronic_disease
pulmonary 34 43 2670 2679 I-chronic_disease
dysfunction 44 55 2680 2691 I-chronic_disease

Subjects 0 8 2692 2700 O
with 9 13 2701 2705 O
stable 14 20 2706 2712 O
and 21 24 2713 2716 O
adequately 25 35 2717 2727 O
treated 36 43 2728 2735 O
hypothyroidism 44 58 2736 2750 B-chronic_disease
, 58 59 2750 2751 O
reflected 60 69 2752 2761 O
by 70 72 2762 2764 O
normal 73 79 2765 2771 O
TSH 80 83 2772 2775 B-clinical_variable
values 84 90 2776 2782 I-clinical_variable

Total 0 5 2783 2788 B-clinical_variable
testosterone 6 18 2789 2801 I-clinical_variable
> 19 20 2802 2803 O
150 21 24 2804 2807 B-lower_bound
ng 25 27 2808 2810 I-lower_bound
/ 27 28 2810 2811 I-lower_bound
dL 28 30 2811 2813 I-lower_bound
, 30 31 2813 2814 O
which 32 37 2815 2820 O
suggests 38 46 2821 2829 O
the 47 50 2830 2833 O
possibility 51 62 2834 2845 O
of 63 65 2846 2848 O
a 66 67 2849 2850 O
virilizing 68 78 2851 2861 B-chronic_disease
neoplasm 79 87 2862 2870 I-chronic_disease

Virilization 0 12 2871 2883 B-chronic_disease

females 0 7 2884 2891 B-gender

